Growing tumors induce a local STING dependent Type I IFN response in dendritic cells.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Brinkmann, Melanie M
MetadataShow full item record
AbstractThe importance of endogenous Type I IFNs in cancer immune surveillance is well established by now. Their role in polarization of tumor-associated neutrophilic granulocytes into anti-tumor effector cells has been recently demonstrated. Yet, the cellular source of Type I IFNs as well as the mode of induction is not clearly defined. Here, we demonstrate that IFN-β is induced by growing murine tumors. Induction is mainly mediated via STING-dependent signaling pathways, suggesting tumor derived DNA as trigger. Transcription factors IRF3 and IRF5 were activated under these conditions which is consistent with tumor infiltrating dendritic cells (DCs) being the major cellular source of IFN-β at the tumor site. Besides DCs, tumor cells themselves are induced to contribute to the production of IFN-β. Taken together, our data provide further information on immune surveillance by Type I IFNs and suggest novel potent cellular targets for future cancer therapy.
CitationGrowing tumors induce a local STING dependent Type I IFN response in dendritic cells. 2016, 139 (6):1350-7 Int. J. Cancer
AffiliationHelmholtz Centre for infection research, Inhoffenstr. 7, 38124 Braunschweig, Germany.
JournalInternational journal of cancer
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/
- STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
- Authors: Demaria O, De Gassart A, Coso S, Gestermann N, Di Domizio J, Flatz L, Gaide O, Michielin O, Hwu P, Petrova TV, Martinon F, Modlin RL, Speiser DE, Gilliet M
- Issue date: 2015 Dec 15
- STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells.
- Authors: Klarquist J, Hennies CM, Lehn MA, Reboulet RA, Feau S, Janssen EM
- Issue date: 2014 Dec 15
- STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment.
- Authors: Ohkuri T, Ghosh A, Kosaka A, Zhu J, Ikeura M, David M, Watkins SC, Sarkar SN, Okada H
- Issue date: 2014 Dec
- Tick-borne flaviviruses antagonize both IRF-1 and type I IFN signaling to inhibit dendritic cell function.
- Authors: Robertson SJ, Lubick KJ, Freedman BA, Carmody AB, Best SM
- Issue date: 2014 Mar 15
- MPYS/STING-mediated TNF-α, not type I IFN, is essential for the mucosal adjuvant activity of (3'-5')-cyclic-di-guanosine-monophosphate in vivo.
- Authors: Blaauboer SM, Gabrielle VD, Jin L
- Issue date: 2014 Jan 1